The critical detail most teams miss is that AMS access is OBP-based, not MAH-based and as defined by EMVO, OBPs can create users and structure them into teams to control alert visibility by market. The practical implication is that onboarding success depends on how entities, teams, market coverage, and ownership...
Blog
EMVO AMS and EAMS Explained for MAHs
The European Medicines Verification System (EMVS) only works at scale when alerts are handled quickly, consistently, and with high-quality data. A single alert at dispensing can trigger quarantine procedures, investigations, and communication with national verification organizations. When this happens across hundreds of SKUs, multiple CMOs, and many European markets, the...
DSCSA in 2026: Full Electronic Interoperability Across Digital Transformation and Daily Operations
This article focuses on DSCSA from an operational execution perspective, how interoperability behaves inside daily warehouse, quality, and supply chain workflows.
Whitepaper: NDC12 – Revising the National Drug Code Format and Drug Label Barcode Requirements for the U.S. Market
This white paper blends the original high-level summary with a more detailed narrative, offering both clear structure and practical depth. It explains the new NDC format, explores stakeholder impacts, describes the implications for GTIN, and outlines concrete next steps and emerging solution options.
Hyperautomation Hits Pharma: Merging RPA and AI for End-to-End Supply Chain Efficiency
This blog post will explore the power of hyperautomation, its most impactful applications, and the strategic guidance needed to navigate the inevitable workforce and cultural shifts, highlighting quick wins that many competitors overlook.
